Articles

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

Adult BMT Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Montefiore Medical Center, New York, NY, USA
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Mayo Clinic, Rochester MN, USA
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
University College London, London, UK
Imperial College, London, UK
University College London, London, UK
Mayo Clinic, Rochester MN, USA
University of Pennysylvania, Philadelphia, PA, USA
Nottingham City Hospital, Nottingham, UK
Montefiore Medical Center, New York, NY, USA
Shaare Zedek Medical Center, Jerusalem, Israel
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Montefiore Medical Center, New York, NY, USA
Case Western Reserve University, University Hospitals Case Medical Center, Cleveland OH, USA
Vol. 98 No. 6 (2013): June, 2013 https://doi.org/10.3324/haematol.2012.081877